Publications

The regulation of liver cytochrome P450 expression and activity by the brain serotonergic system in different experimental models. Ewa Bromek, Władysława Anna Daniel
Expert opinion on drug metabolism & toxicology, 10.1080/17425255.2021.1872543
PMID:33400885
Monday, 18 January 2021
Cytochrome P450 expression and regulation in the brain. Wojciech Kuban, Władysława Anna Daniel
Drug metabolism reviews, 10.1080/03602532.2020.1858856
PMID:33356626
Sunday, 27 December 2020
The effect of ageing and cerebral serotonin deficit on the activity of cytochrome P450 2D (CYP2D) in the brain and liver of male rats. Anna Haduch, Renata Pukło, Natalia Alenina, Agnieszka Nikiforuk, Piotr Popik, Michael Bader, Władysława A Daniel
Neurochemistry international, S0197-0186(20)30275-8 10.1016/j.neuint.2020.104884
PMID:33091481
Monday, 19 October 2020
Asenapine and iloperidone decrease the expression of major cytochrome P450 enzymes CYP1A2 and CYP3A4 in human hepatocytes. A significance for drug-drug interactions during combined therapy. Przemysław J Danek, Jacek Wójcikowski, Władysława A Daniel
Toxicology and applied pharmacology, S0041-008X(20)30365-3 10.1016/j.taap.2020.115239
PMID:32941854
Monday, 14 September 2020
Levomepromazine and clozapine induce the main human cytochrome P450 drug metabolizing enzyme CYP3A4. Przemysław J Danek, Agnieszka Basińska-Ziobroń, Jacek Wójcikowski, Władysława A Daniel
Pharmacological reports : PR, 10.1007/s43440-020-00157-4
PMID:32888176
Friday, 4 September 2020
The effects of agomelatine and imipramine on liver cytochrome P450 during chronic mild stress (CMS) in the rat. Anna Haduch, Ewa Bromek, Marta Rysz, Renata Pukło, Mariusz Papp, Piotr Gruca, Magdalena Łasoń, Monika Niemczyk, Władysława A Daniel
Pharmacological reports : PR, 10.1007/s43440-020-00151-w
PMID:32748256
Monday, 3 August 2020
The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions. Przemysław J Danek, Jacek Wójcikowski, Władysława A Daniel
Pharmacological reports : PR, 10.1007/s43440-020-00102-5
PMID:32279279
Saturday, 11 April 2020
In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions. Jacek Wójcikowski, Przemysław J Danek, Agnieszka Basińska-Ziobroń, Renata Pukło, Władysława A Daniel
Pharmacological reports : PR, 10.1007/s43440-020-00089-z
PMID:32219694
Thursday, 26 March 2020
Replication fidelity in E. coli: Differential leading and lagging strand effects for dnaE antimutator alleles. Karolina Makiela-Dzbenska, Katarzyna H Maslowska, Wojciech Kuban, Damian Gawel, Piotr Jonczyk, Roel M Schaaper, Iwona J Fijalkowska
DNA repair, S1568-7864(19)30163-6 10.1016/j.dnarep.2019.102643
PMID:31324532
Thursday, 4 July 2019
undefined Ewa Bromek, Marta Rysz, Anna Haduch, Władysława A Daniel
Pharmacological reports : PR, S1734-1140(19)30210-5 10.1016/j.pharep.2019.05.010
PMID:31671379
Friday, 17 May 2019